Nine cases of severe side effects linked to vaccines in recent AEFI report

Of these nine cases, five were vaccine product related reactions, four were immunisation anxiety related reactions

India vaccination, Covid-19 vaccination
Vaccine product related reactions are expected reactions that can be attributed to vaccination based on current scientific evidence
Sohini Das Mumbai
2 min read Last Updated : Dec 04 2021 | 12:07 AM IST
The Union Health Ministry's recent analysis of serious adverse events following immunisation (AEFI) of 22 cases show that nine had causal link or association to vaccination.

The results of the causality assessment for 22 cases completed on October 18, 2021 after review by the National AEFI Committee showed that nine cases had causal link to vaccination. Of these nine cases, five were vaccine product related reactions, and four were immunisation anxiety related reactions. The report said that 12 cases have inconsistent causal association to vaccination (coincidental - not linked to vaccination), including five death cases. There was one death in the indeterminate category.

Vaccine product related reactions are expected reactions that can be attributed to vaccination based on current scientific evidence. Examples of such reactions are allergic reactions and anaphylaxis, etc. Indeterminate reactions are reactions which have occurred soon after vaccination but there is no definitive evidence in current literature or clinical trial data that this event could have been caused due to the vaccine. Further observations, analysis and studies are required in such cases.

Coincidental events are events that are reported following immunization but for which a clear cause other than vaccination is found on investigation.  

Of the cases found to be linked to vaccination, a 21 year old female had anaphylaxis (allergic shock) which was severe, but she recovered. There have been two more cases of anaphylaxis. Another 44 year old female was hospitalised with fever, headache and vomiting. She recovered. A 25 year old male had an allergic rash, and was hospitalised.

The government report said that  "Overall, the benefits of vaccination are overwhelmingly greater than the small risk of harm. However, as a measure of utmost precaution, all emerging signals of harm are being constantly tracked and reviewed periodically."

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusDelta variant of coronavirusHealth MinistryCoronavirus VaccineCoronavirus Tests

Next Story